Welcome to our dedicated page for Marpai SEC filings (Ticker: MRAI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Searching Marpai’s SEC disclosures often means digging through dense healthcare regulations, AI R&D costs, and dozens of reimbursement tables. Locating Marpai insider trading Form 4 transactions or the latest technology spend hidden in a 300-page 10-K can consume hours.
Stock Titan solves that overwhelm. Our AI reads every Marpai quarterly earnings report 10-Q filing, flags margin shifts inside the benefits administration segment, and delivers plain-English highlights in seconds. Need real-time alerts? We stream Marpai Form 4 insider transactions real-time so you see executive moves before markets react. From Marpai 8-K material events explained to a Marpai proxy statement executive compensation breakdown, each document is summarized, linked, and searchable.
What you’ll uncover with one click:
- Cash burn, client count, and AI platform investment pulled from the Marpai annual report 10-K simplified.
- Quarter-over-quarter claims volume trends drawn from earnings data and presented as visual dashboards.
- Automated red-flag alerts on related-party deals, insider gifts, and Marpai executive stock transactions Form 4.
Whether you’re comparing cost-containment efficiency, monitoring Marpai earnings report filing analysis, or simply understanding Marpai SEC documents with AI, our platform delivers every filing type the moment EDGAR releases it—no jargon, no delay, just actionable clarity.
Marpai has announced its Annual Meeting of Stockholders to be held on August 27, 2025 in Tampa, FL. Shareholders will vote on three key proposals:
- Election of six directors for one-year terms, including CEO Damien Lamendola and five other nominees
- Ratification of UHY LLP as independent auditor for FY2025
- Amendment to authorize 2,000,000 shares of blank-check preferred stock with terms to be determined by the Board
The record date is set for June 30, 2025. Shareholders can vote by mail, in person, or online through designated platforms. The Board unanimously recommends voting "FOR" all proposals. This preliminary proxy statement outlines important voting procedures, including requirements for quorum and the ability to revoke or change votes prior to poll closing.